{"altmetric_id":1715624,"counts":{"readers":{"mendeley":28,"citeulike":0,"connotea":0},"news":{"unique_users_count":4,"unique_users":["scicasts","health_canal","medicalxpress","science_daily"],"posts_count":4},"total":{"posts_count":13},"twitter":{"unique_users_count":7,"unique_users":["mtmdphd","DrMiguelPerales","j_jay_z","CancerCureNow","Aiims1742","Sinchita_Roy","yingma_maying"],"posts_count":9}},"selected_quotes":["CD40 #PancreaticCancer #immunotherapy","A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemci","Ph I study of an agonist CD40 Ab w\/ gemcitabine in advanced pancreatic ductal adenocarcinoma #ImmunoOnc","Phase I Study of an Agonist CD40 mAb (CP-870,893)+ Gemcitabine in Advanced Pancreas CA - Beatty CCR #pancsm"],"citation":{"abstract":"This phase I study investigated the maximum-tolerated dose (MTD), safety, pharmacodynamics, immunologic correlatives, and antitumor activity of CP-870,893, an agonist CD40 antibody, when administered in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma (PDA).","abstract_source":"pubmed","altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Gregory L Beatty","Drew A Torigian","E. Gabriela Chiorean","Babak Saboury","Alex Brothers","Abass Alavi","Weijing Sun","Ursina R Teitelbaum","Robert H Vonderheide","Peter O'Dwyer","Beatty GL","Torigian DA","Chiorean EG","Saboury B","Brothers A","Alavi A","Sun W","Teitelbaum UR","Vonderheide RH","O'Dwyer P"],"doi":"10.1158\/1078-0432.ccr-13-1320","endpage":"6295","first_seen_on":"2013-08-28T12:27:34+00:00","funders":["nci"],"issns":["1557-3265","1078-0432"],"issue":"22","journal":"Clinical Cancer Research","last_mentioned_on":1456960291,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/08\/24\/1078-0432.CCR-13-1320.abstract.html?papetoc","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/08\/31\/1078-0432.CCR-13-1320.long","http:\/\/dx.doi.org\/10.1158\/1078-0432.CCR-13-1320","http:\/\/clincancerres.aacrjournals.org\/content\/19\/22\/6286.abstract.html?etoc","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23983255?dopt=Citation","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/23983255\/?i=4&from=beatty%20cd40"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2013\/08\/24\/1078-0432.CCR-13-1320.full.pdf","pmid":"23983255","pubdate":"2013-01-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"6286","title":"A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.","type":"article","volume":"19","mendeley_url":"http:\/\/www.mendeley.com\/research\/phase-i-study-agonist-cd40-monoclonal-antibody-cp870893-combination-gemcitabine-patients-advanced-pa-1"},"altmetric_score":{"score":32.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":32.25},"context_for_score":{"all":{"total_number_of_other_articles":7342039,"mean":6.3783632029643,"rank":221204,"this_scored_higher_than_pct":96,"this_scored_higher_than":7120551,"rank_type":"exact","sample_size":7342039,"percentile":96},"similar_age_3m":{"total_number_of_other_articles":128956,"mean":6.9553469349775,"rank":5027,"this_scored_higher_than_pct":96,"this_scored_higher_than":123921,"rank_type":"exact","sample_size":128956,"percentile":96},"this_journal":{"total_number_of_other_articles":5031,"mean":5.4472242544732,"rank":138,"this_scored_higher_than_pct":97,"this_scored_higher_than":4893,"rank_type":"exact","sample_size":5031,"percentile":97},"similar_age_this_journal_3m":{"total_number_of_other_articles":10,"mean":5.4335555555556,"rank":2,"this_scored_higher_than_pct":80,"this_scored_higher_than":8,"rank_type":"exact","sample_size":10,"percentile":80}}},"demographics":{"poster_types":{"member_of_the_public":6,"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1,"Members of the public":6}},"mendeley":{"by_status":{"Professor > Associate Professor":2,"Researcher":12,"Student  > Ph. D. Student":7,"Student  > Postgraduate":1,"Student  > Master":1,"Other":2,"Student  > Bachelor":1,"Professor":2},"by_discipline":{"Engineering":2,"Medicine and Dentistry":11,"Neuroscience":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":11,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"US":5},"mendeley":{"BE":1,"FR":1}}},"posts":{"news":[{"title":"Researchers Harness the Immune System to Fight Pancreatic Cancer","url":"http:\/\/scicasts.com\/cancer-research\/2067-cancer-drugs\/6671-researchers-harness-the-immune-system-to-fight-pancreatic-cancer?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed:%20scicasts\/news%20(Breaking%20Sci-Tech%20News%20|%20Scicasts)","license":"public","citation_ids":[1715624],"posted_on":"2013-09-24T21:39:20+00:00","summary":"Philadelphia, PA (Scicasts) \u2013 Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and","author":{"name":"Scicasts","url":"http:\/\/scicasts.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/310\/normal\/Screen_Shot_2016-02-02_at_17.16.41.png?1454433412"}},{"title":"Penn Medicine Researchers Harness the Immune System to Fight Pancreatic Cancer","url":"http:\/\/www.healthcanal.com\/immune-system\/43187-penn-medicine-researchers-harness-the-immune-system-to-fight-pancreatic-cancer.html","license":"public","citation_ids":[1715624],"posted_on":"2013-09-23T21:28:00+00:00","summary":"Study Reveals Separate Tumor Sites Respond Differently to New Immunotherapy, Highlights the Power of New Real-Time Imaging Technique to Study Response","author":{"name":"Health Canal","url":"http:\/\/www.healthcanal.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/221\/normal\/image.png?1370446573"}},{"title":"Researchers harness immune system to fight pancreatic cancer","url":"http:\/\/medicalxpress.com\/news\/2013-09-harness-immune-pancreatic-cancer.html","license":"public","citation_ids":[1715624],"posted_on":"2013-09-24T13:50:02+00:00","summary":"(Medical Xpress)\u2014Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and frequently, i","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"Researchers harness the immune system to fight pancreatic cancer","url":"http:\/\/www.sciencedaily.com\/releases\/2013\/09\/130924135205.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29","license":"public","citation_ids":[1715624],"posted_on":"2013-09-24T17:52:52+00:00","summary":"Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and frequently, its late stage at","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}}],"twitter":[{"url":"http:\/\/twitter.com\/mtmdphd\/status\/401323396824592384","license":"public","citation_ids":[1715624],"posted_on":"2013-11-15T12:18:48+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"401323396824592384"},{"url":"https:\/\/twitter.com\/DrMiguelPerales\/status\/530093126887960577","license":"datasift","citation_ids":[1715624],"posted_on":"2014-11-05T20:23:44+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6529},"tweet_id":"530093126887960577"},{"url":"https:\/\/twitter.com\/j_jay_z\/status\/530195599807623170","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[1715624],"posted_on":"2014-11-06T03:10:56+00:00","author":{"name":"joyz","image":"https:\/\/pbs.twimg.com\/profile_images\/512086208214605825\/yL1wweGf_normal.jpeg","id_on_source":"j_jay_z","tweeter_id":"229862784","geo":{"lt":null,"ln":null},"followers":90},"tweet_id":"530195599807623170"},{"url":"http:\/\/twitter.com\/CancerCureNow\/statuses\/372696932881149952","license":"public","citation_ids":[1715624],"posted_on":"2013-08-28T12:27:27+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8381},"tweet_id":"372696932881149952"},{"url":"https:\/\/twitter.com\/CancerCureNow\/status\/375615284880474112","license":"public","citation_ids":[1715624],"posted_on":"2013-09-05T13:43:57+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8381},"tweet_id":"375615284880474112"},{"url":"https:\/\/twitter.com\/Aiims1742\/status\/373806198719807488","license":"public","citation_ids":[1715624],"posted_on":"2013-08-31T13:55:17+00:00","author":{"name":"Anirban Maitra","url":"https:\/\/www.mdanderson.org\/research\/departments-labs-institutes\/labs\/maitra-laboratory.html","image":"https:\/\/pbs.twimg.com\/profile_images\/884178778842443781\/KdCPRIXj_normal.jpg","description":"Scientific Director of the Ahmed Center for Pancreatic Cancer Research at MD Anderson Cancer Ctr. Also a GI Pathologist. Tweets & opinions expressed are my own.","id_on_source":"Aiims1742","tweeter_id":"166816694","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":4808},"tweet_id":"373806198719807488"},{"url":"http:\/\/twitter.com\/Aiims1742\/statuses\/705086215192580096","license":"gnip","citation_ids":[5955390,1715624,130666],"posted_on":"2016-03-02T17:43:48+00:00","author":{"name":"Anirban Maitra","url":"https:\/\/www.mdanderson.org\/research\/departments-labs-institutes\/labs\/maitra-laboratory.html","image":"https:\/\/pbs.twimg.com\/profile_images\/884178778842443781\/KdCPRIXj_normal.jpg","description":"Scientific Director of the Ahmed Center for Pancreatic Cancer Research at MD Anderson Cancer Ctr. Also a GI Pathologist. Tweets & opinions expressed are my own.","id_on_source":"Aiims1742","tweeter_id":"166816694","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":4808},"tweet_id":"705086215192580096"},{"url":"http:\/\/twitter.com\/Sinchita_Roy\/statuses\/705090800095518721","license":"gnip","rt":["Aiims1742"],"citation_ids":[5955390,1715624,130666],"posted_on":"2016-03-02T18:02:01+00:00","author":{"name":"Sinchita Roy MD PhD","image":"https:\/\/pbs.twimg.com\/profile_images\/603933471031992320\/nYfQMhF0_normal.jpg","description":"Cytopathologist & Molecular Pathologist at MD Anderson Cancer Center, Director of Molecular Cytopathology @MDAndersonNews #cytology #molpath #cytopathologist","id_on_source":"Sinchita_Roy","tweeter_id":"3228442466","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":1661},"tweet_id":"705090800095518721"},{"url":"http:\/\/twitter.com\/yingma_maying\/statuses\/705168689515986944","license":"gnip","rt":["Aiims1742"],"citation_ids":[5955390,1715624,130666],"posted_on":"2016-03-02T23:11:31+00:00","author":{"name":"Ying Ma","url":"http:\/\/www.scopus.com\/authid\/detail.url?authorId=55790985600","image":"https:\/\/pbs.twimg.com\/profile_images\/533757055308288000\/CeKZT7Sn_normal.jpeg","description":"Immunologist\/pathologist on pancreatic cancer research at UT MD Anderson Cancer Center. \nhttps:\/\/www.linkedin.com\/in\/ying-ma-0691b448\/","id_on_source":"yingma_maying","tweeter_id":"2900926058","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":59},"tweet_id":"705168689515986944"}]}}